MLRagent

Respond publicly to an off-label request only when it names the firm's own product

AI-verifiedwarningFDA guidance · non-bindingRaised as a question — a person decides

Rule

A firm should respond to a public unsolicited off-label request only when the request pertains specifically to the firm's own named product, not solely to a competitor's product.

Check

Check that the public request being answered names or specifically concerns the firm's own product rather than only a competitor's product or a generic/unnamed drug class question.

Escalate when

Whether the original question was specific enough to the firm's named product is unclear.

Where this comes from

Section VI, Recommendation 1 · page 14. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

…detailed public online responses to off-label questions because specific drug or device information may become outdated (e.g., new risk information may become available). FDA makes the following recommendations to a firm that chooses to respond to public unsolicited requests for off-label information about its product(s), including those encountered through emerging electronic media. 1. If a firm chooses to respond to public unsolicited requests for off-label information, the firm should respond only when the request pertains specifically to its own named product (and is not solely about a competitor’s product). The level of specificity of the question posed in a public forum is important in determining the appropriateness of a firm responding to the unsolicited request. Example 13: An individual poses the specific question “Can Drug/Device X be used for Condition Y” in a public forum (and this question is not prompted by or on behalf of the firm). It may be appropriate for the firm to respond as outlined below becau…
Document
FDA guidance: Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices (see document)
Version
as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
Retrieved
2026-09-21 from www.fda.gov
Fingerprint
8ab6bfda34ad39a70987805b…

FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.